Related Experiment Video
Updated: May 23, 2026
07:25
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
25-Hydroxyvitamin D3 suppresses hepatitis C virus production
Takuya Matsumura1, Takanobu Kato, Nao Sugiyama
1Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Hepatology (Baltimore, Md.)
|April 11, 2012
Summary
25-hydroxyvitamin D(3) effectively inhibits hepatitis C virus (HCV) by targeting viral assembly. This discovery offers a new therapeutic strategy, particularly for patients with liver dysfunction, improving upon current interferon-based treatments.
Area of Science:
- Hepatology
- Virology
- Endocrinology
Background:
- Current interferon (IFN)-based treatments for hepatitis C virus (HCV) infection are limited by side effects and therapeutic efficacy.
- Vitamin D supplementation has shown promise in improving sustained viral response with IFN-based therapy, but its precise anti-HCV mechanisms and active forms remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms and identify the active form of vitamin D responsible for anti-HCV effects.
- To investigate the specific stage of the HCV life cycle targeted by vitamin D metabolites.
Main Methods:
- HCV-infected HuH-7 cells were treated with vitamin D(3) or its metabolites (25-hydroxyvitamin D(3) and 1,25-dihydroxyvitamin D(3)).
- Concentrations of HCV core antigen were measured intracellularly and extracellularly.
- Single-cycle virus production assays were performed using a CD81-negative cell line.
- HCV mutants resistant to 25-hydroxyvitamin D(3) were generated and analyzed.
Main Results:
- 25-hydroxyvitamin D(3) significantly reduced HCV core antigen levels in a dose-dependent manner, while vitamin D(3) and 1,25-dihydroxyvitamin D(3) had no effect.
- The antiviral activity of 25-hydroxyvitamin D(3) was localized to the viral assembly stage, not affecting viral entry or replication.
- Long-term treatment led to the emergence of a resistant HCV mutant with an N1279Y substitution in the NS3 helicase domain.
Conclusions:
- 25-hydroxyvitamin D(3) is a novel anti-HCV agent that specifically inhibits infectious viral particle assembly.
- This finding supports the combination of vitamin D(3) and IFN for enhanced HCV treatment efficacy.
- 25-hydroxyvitamin D(3) presents a superior therapeutic option compared to vitamin D(3) for patients with hepatic dysfunction.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:16Hepatic Drug Excretion: Influencing Factors
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...